Remsima 100 mg
Remsima 100 mg is a medicine authorised by Swissmedic under authorisation number 68734. The authorisation holder is APS-Arzneimittel-Parallelimport- Service AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 June 2022 and the authorisation is limited until 15 June 2027. ATC code L04AB02 places the medicine in the group Immunosuppressants.
| Authorisation number | 68734 |
|---|---|
| Name | Remsima 100 mg |
| Full name | Remsima 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | APS-Arzneimittel-Parallelimport- Service AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AB02 |
| First authorisation | 16 June 2022 |
| Authorisation validity | 15 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Remsima 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 16 June 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | Durchstechflasche(n) | L04AB02 | 07.15.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Remsima 100 mg authorised in Switzerland?
Yes. Remsima 100 mg is authorised by Swissmedic under authorisation number 68734, data as of 01 September 2026. The authorisation is limited until 15 June 2027.
Which dispensing category does Remsima 100 mg have?
Remsima 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Remsima 100 mg?
The authorisation holder is APS-Arzneimittel-Parallelimport- Service AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.